Cagrilintide is a novel, long acting peptide designed to target multiple receptors involved in appetite regulation and energy balance. Unlike traditional weight loss medications that often target a single pathway, cagrilintide acts as Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed CAGRILINTIDE PEPTIDE 5MG 10MG VIAL UMBRELLA Labs Comparative Efficacy and Safety of Semaglutide, Cagrilintide, and CagriSema in Adults with Overweight or Obesity: A Bayesian Network Meta Analysis Journal of Clinical Question Weight Loss Efficacy of Cagrilintide and Semaglutide gutsandgrowth Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect